THERAPEUTIC PHARMACOS FOR DERMATITIS, WHICH PRESENT A BIFASSIC CUTANEOUS REACTION AND CONTAINING QUIMASA INHIBITORS AS ACTIVE INGREDIENT.

摘要

The use of a chymase inhibitor as an active ingredient in the manufacture of a medicament for the treatment of dermatitis that shows a biphasic skin reaction.